Seçki · Sağlık

Big pharma

InspectStocks tarafındanPublished 14 Eki 202613 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

Bir yapay zekâ modelinin yardımıyla gruplandı ve editörlerimizce gözden geçirildi. Her şirketin altındaki satır, neden burada olduğunu söyler.

Download image

Kartlar Seviyeler

Hisse fiyatları 11 Kas 2026 kapanış fiyatlarıdır, IEX borsa verisinden.

Grade mix

A 7B 3C 3

Revenue growing

12 of 12

Free cash flow growing

9 of 13

Median price move, 1 year

+%34,0

Sort by

LLYELI LILLY AND COMPANY
Drug manufacturers generalMarket cap $1,35TP/E 46,67
$1.437,79+%42,21Y
Since added +%23,2
A+
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Güçlü
Getting better
İyileşiyor
Revenue
$86,5B+%45,5
Profit
$27,6B+%49,8
Free cash flow
$19,7B+%112,1
Discuss
Why it is here: Sells prescription medicines for diabetes, obesity, cancer and inflammation
JNJJohnson & Johnson
Drug manufacturers generalMarket cap $674,9BP/E 42,54
$280,34+%47,51Y
Since added +%12,8
A+
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Güçlü
Getting better
Karışık
Revenue
$99,3B+%7,8
Profit
$16,1B-%35,9
Free cash flow
$20,6B+%5,1
Discuss
Why it is here: Sells prescription medicines for cancer and immune disorders
ABBVAbbVie Inc.
Drug manufacturers generalMarket cap $521,2BP/E 50,75
$294,87+%30,21Y
Since added +%7,5
B+
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Güçlü
Getting better
İyileşiyor
Revenue
$66B+%10,7
Profit
$10,3B+%333,1
Free cash flow
$18,9B-%4,1
Discuss
Why it is here: Sells medicines for immune, neurological and cancer conditions
MRKMerck & Co., Inc.
Drug manufacturers generalMarket cap $362,9BP/E 150,20
$147,20+%65,71Y
Since added +%3,7
A
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Sağlam
Getting better
Karışık
Revenue
$67,4B+%4,9
Profit
$2,5B-%87,1
Free cash flow
$14,7B+%13,0
Discuss
Why it is here: Sells prescription medicines and vaccines for people and animals
NVSNovartis AG
Drug manufacturers generalMarket cap $306BF/K yok (faaliyet zararı)
$160,36+%23,61Y
Since added +%12,6
A
Büyüme ve nakit
Güçlü büyüyor
Business quality
Karışık
Getting better
Belirgin biçimde iyileşiyor
Revenue
$56,7B+%9,6
Profit
-$46MNo comparable year
Free cash flow
$17,6B+%8,3
Discuss
Why it is here: Sells prescription medicines
AZNASTRAZENECA PLC
Drug manufacturers generalMarket cap $289,7BP/E 28,36
$185,49+%115,21Y
Since added +%19,0
B+
Büyüme ve nakit
Güçlü büyüyor
Business trend
Yavaşlıyor
Business quality
Güçlü
Getting better
Belirgin biçimde iyileşiyor
Revenue
$62,4B+%7,3
Profit
$10,2B+%45,3
Free cash flow
$11,8B+%18,4
Discuss
Why it is here: Sells prescription medicines
NVONOVO NORDISK A/S
Drug manufacturers generalMarket cap $182,8BP/E 11,84
$41,10-%15,41Y
Since added +%8,0
C+
Büyüme ve nakit
Büyüyor
Business trend
Hızlanıyor
Business quality
Güçlü
Getting better
İyileşiyor
Revenue
$50,3B+%5,7
Profit
$17,1B+%9,1
Free cash flow
$8,9B-%20,1
Discuss
Why it is here: Sells diabetes and obesity medicines
PFEPFIZER INC
Drug manufacturers generalMarket cap $167,9BP/E 42,07
$29,45+%21,41Y
Since added +%3,8
C
Büyüme ve nakit
Güçlü büyüyor
Business trend
Daralıyor
Business quality
Sağlam
Getting better
Karışık
Revenue
$63,6B+%1,3
Profit
$4B-%59,0
Free cash flow
$11,8B+%13,6
Discuss
Why it is here: Sells prescription medicines and vaccines
BMYBRISTOL-MYERS SQUIBB COMPANY
Drug manufacturers generalMarket cap $128,6BP/E 13,95
$62,92+%34,01Y
Since added +%11,0
C+
Büyüme ve nakit
Büyüyor
Business trend
İstikrarlı
Business quality
Güçlü
Getting better
Belirgin biçimde iyileşiyor
Revenue
$50B+%4,2
Profit
$9,2B+%53,1
Free cash flow
$9,3B-%39,3
Discuss
Why it is here: Sells prescription medicines for cancer and immune conditions
SNYSanofi
Drug manufacturers generalMarket cap $59,1BP/E 6,81
$48,43-%3,01Y
Since added +%23,9
B
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Karışık
Getting better
İyileşiyor
Revenue
$53,5B+%11,6
Profit
$4,7B-%54,2
Free cash flow
$8,1B+%22,5
Discuss
Why it is here: Sells prescription medicines and vaccines
GSKGSK plc
Drug manufacturers generalMarket cap $109,2BP/E 13,60
$50,60+%8,91Y
Since added +%9,3
A+
Büyüme ve nakit
Güçlü büyüyor
Business quality
Güçlü
Getting better
Belirgin biçimde iyileşiyor
Revenue
$43,8B+%4,1
Profit
$7,7B+%122,0
Free cash flow
$8,6B+%24,0
Discuss
Why it is here: Sells prescription medicines and vaccines worldwide
AMGNAmgen Inc.
Drug manufacturers generalMarket cap $253,2BP/E 27,14
$468,13+%43,11Y
Since added +%13,4
A+
Büyüme ve nakit
Güçlü büyüyor
Business trend
İstikrarlı
Business quality
Güçlü
Getting better
İyileşiyor
Revenue
$38,9B+%8,2
Profit
$9,4B+%34,1
Free cash flow
$9,6B-%17,0
Discuss
Why it is here: Develops and sells medicines and biosimilars for serious diseases
TAKTakeda Pharmaceutical Company Limited
Drug manufacturers specialty and genericMarket cap $33,5BP/E 48,79
$20,86+%50,11Y
Since added +%12,5
A
Büyüme ve nakit
Güçlü büyüyor
Business quality
Karışık
Getting better
Karışık
Revenue
$29,8BNo comparable year
Profit
$259,4MNo comparable year
Free cash flow
$5,5B+%1,1
Discuss
Why it is here: Sells prescription medicines and vaccines globally

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Be civil and stick to the companies. Comments are opinions, not advice.

Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.